ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000263182.1	Avagacestat	Head and neck squamous cell carcinoma	0.018359572	Resistant
ENSG00000263182.1	Avagacestat	Colon adenocarcinoma	0.036993258	Sensitive